Mouthwash recall
This article was originally published in The Tan Sheet
Executive Summary
Hydrox Labs issues a voluntary recall of Cardinal Health alcohol-free mouthwash after it tested positive for Burkholderia cepacia, the Elgin, Ill.-based firm announces May 2. B. cepacia may cause people who have weakened immune systems or chronic lung diseases to be more susceptible to infections and the effects vary widely ranging from no symptoms to serious respiratory infections. The Centers for Disease Control and Prevention confirmed hospital illnesses in one state associated with the use of the affected mouthwash, according to Hydrox Labs. The product was distributed to hospitals, medical centers and long-term care facilities nationwide in certain personal hygiene admission kits, Hydrox Labs says. The lot number of the affected product is 26228, according to the firm...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.